La Jolla, CA, United States of America

Elisa Barile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • San Diego, CA (US) (2011)
  • La Jolla, CA (US) (2016)

Company Filing History:


Years Active: 2011-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Elisa Barile: Innovator in Pharmaceutical Research

Introduction

Elisa Barile is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of pharmaceutical research, particularly in the development of inhibitors for various diseases. With a total of two patents to her name, her work focuses on innovative solutions for treating infectious diseases, cancers, and inflammatory disorders.

Latest Patents

Elisa Barile's latest patents include "Inhibitors of Furin and other pro-protein convertases" and "Pyrazole derivatives as kinase inhibitors." The first patent discloses Furin/PC inhibitors designed to inhibit Furin and other pro-protein convertases. It details methods for making these inhibitors, their chemical and biological characterization, and their potential use in treating various diseases. The second patent provides compounds with a specific structure that can be used as pharmaceutical compositions for treating disorders such as cancers.

Career Highlights

Throughout her career, Elisa has worked with esteemed institutions such as the Sanford Burnham Medical Research Institute and the Burnham Institute for Medical Research. Her research has been pivotal in advancing the understanding of kinase inhibitors and their applications in medicine.

Collaborations

Elisa has collaborated with notable colleagues, including Maurizio Pellecchia and Alex Strongin. These partnerships have enhanced her research and contributed to the development of her innovative patents.

Conclusion

Elisa Barile is a remarkable inventor whose work in pharmaceutical research has the potential to impact the treatment of various diseases significantly. Her patents reflect her dedication to innovation and her commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…